3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Multiple Myeloma
2
Colorectal Neoplasms
2
Uterine Cervical Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteonecrosis
1
Lymphoma
1
Lung Neoplasms
1
Hypertension
1
Hematologic Neoplasms
1
Depression
1
Bone Neoplasms
1
Anxiety Disorders
1
Anatomic Stage I Breast Cancer AJCC v8
1
Acquired Immunodeficiency Syndrome
1
Interventions
Gemcitabine
31
Cisplatin
21
pembrolizumab
8
Fluorouracil
6
Oxaliplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Taxes
4
Albumin-Bound Paclitaxel
4
pemigatinib
3
infigratinib
3
atezolizumab
3
Specimen Handling
3
Radiosurgery
3
Platinum
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Carboplatin
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
trametinib
2
olaparib
2
ivosidenib
2
derazantinib
2
cobimetinib
2
Trastuzumab
2
Radiotherapy
2
Panitumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Cholangiocarcinoma
×
Interviews as Topic
×
Clear all
No trials found.